04 May 2026
A largely solid Q1 with 'only' -4% CER growth
Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
A largely solid Q1 with 'only' -4% CER growth
Novo Nordisk A/S Class B (NOVO.B:CSE) | 0 0 0.0%
- Published:
04 May 2026 -
Author:
ABGSC Healthcare Research | Morten Larsen -
Pages:
13 -